Sao Tome and Principe

Sao Tome and Principe

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
7.13 (5.85 - 8.41) 2019 Modelled IHME
7.84 (6.45 - 9.27) 2018 Modelled IHME
8.15 (6.66 - 9.65) 2017 Modelled IHME
8.08 (6.65 - 9.39) 2016 Modelled IHME
8.01 (6.55 - 9.29) 2015 Modelled IHME
8.12 (6.70 - 9.35) 2014 Modelled IHME
8.39 (6.93 - 9.68) 2013 Modelled IHME
8.75 (7.23 - 10.11) 2012 Modelled IHME
9.13 (7.54 - 10.58) 2011 Modelled IHME
9.46 (7.73 - 11.04) 2010 Modelled IHME
9.75 (8.02 - 11.31) 2009 Modelled IHME
10.02 (8.31 - 11.68) 2008 Modelled IHME
10.3 (8.54 - 12.03) 2007 Modelled IHME
10.58 (8.77 - 12.46) 2006 Modelled IHME
10.86 (8.97 - 12.85) 2005 Modelled IHME
11.17 (9.27 - 13.16) 2004 Modelled IHME
11.5 (9.60 - 13.43) 2003 Modelled IHME
11.81 (9.87 - 13.84) 2002 Modelled IHME
12.09 (10.06 - 14.20) 2001 Modelled IHME
12.3 (10.10 - 14.58) 2000 Modelled IHME
12.46 (10.17 - 14.70) 1999 Modelled IHME
12.6 (10.22 - 14.93) 1998 Modelled IHME
12.72 (10.23 - 15.12) 1997 Modelled IHME
12.82 (10.22 - 15.31) 1996 Modelled IHME
12.88 (10.20 - 15.47) 1995 Modelled IHME
12.93 (10.33 - 15.42) 1994 Modelled IHME
12.98 (10.37 - 15.39) 1993 Modelled IHME
13.02 (10.45 - 15.34) 1992 Modelled IHME
13.07 (10.53 - 15.39) 1991 Modelled IHME
13.1 (10.60 - 15.43) 1990 Modelled IHME
3.54 (0.29 - 24.66) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.93 (0.66 - 1.19) 2019 Modelled IHME
1.01 (0.74 - 1.28) 2018 Modelled IHME
1.06 (0.78 - 1.35) 2017 Modelled IHME
1.07 (0.81 - 1.36) 2016 Modelled IHME
1.08 (0.82 - 1.41) 2015 Modelled IHME
1.09 (0.84 - 1.42) 2014 Modelled IHME
1.12 (0.85 - 1.44) 2013 Modelled IHME
1.15 (0.86 - 1.47) 2012 Modelled IHME
1.19 (0.88 - 1.53) 2011 Modelled IHME
1.24 (0.89 - 1.59) 2010 Modelled IHME
1.34 (0.96 - 1.71) 2009 Modelled IHME
1.52 (1.10 - 1.92) 2008 Modelled IHME
1.77 (1.30 - 2.25) 2007 Modelled IHME
2.1 (1.56 - 2.69) 2006 Modelled IHME
2.49 (1.85 - 3.24) 2005 Modelled IHME
3.45 (2.58 - 4.38) 2004 Modelled IHME
5.16 (3.87 - 6.49) 2003 Modelled IHME
7.08 (5.33 - 8.81) 2002 Modelled IHME
8.72 (6.54 - 10.93) 2001 Modelled IHME
9.56 (7.07 - 12.10) 2000 Modelled IHME
9.8 (7.15 - 12.41) 1999 Modelled IHME
9.99 (7.25 - 12.69) 1998 Modelled IHME
10.14 (7.32 - 12.94) 1997 Modelled IHME
10.24 (7.31 - 13.12) 1996 Modelled IHME
10.3 (7.31 - 13.29) 1995 Modelled IHME
10.34 (7.45 - 13.20) 1994 Modelled IHME
10.37 (7.64 - 13.16) 1993 Modelled IHME
10.4 (7.69 - 13.14) 1992 Modelled IHME
10.41 (7.81 - 13.18) 1991 Modelled IHME
10.42 (7.83 - 13.30) 1990 Modelled IHME
1.36 (0.11 - 11.62) 2015 Modelled WHO
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.3 (7.78 - 15.60) 2019 Modelled IHME
11.3 (7.79 - 15.40) 2018 Modelled IHME
11.2 (7.71 - 15.30) 2017 Modelled IHME
11.2 (7.72 - 15.30) 2016 Modelled IHME
11.3 (7.98 - 15.50) 2015 Modelled IHME
11.9 (8.69 - 15.90) 2014 Modelled IHME
12.4 (9.37 - 16.20) 2013 Modelled IHME
13.1 (10.20 - 17) 2012 Modelled IHME
14.1 (11.10 - 18.10) 2011 Modelled IHME
15.1 (11.80 - 19.40) 2010 Modelled IHME
15.4 (12 - 19.70) 2009 Modelled IHME
15.8 (12.10 - 20.40) 2008 Modelled IHME
16.5 (12.60 - 21.30) 2007 Modelled IHME
16.8 (12.70 - 21.90) 2006 Modelled IHME
16.4 (12.40 - 21.50) 2005 Modelled IHME
17.7 (13.30 - 23.10) 2004 Modelled IHME
17.8 (13.40 - 23.50) 2003 Modelled IHME
18.8 (14.20 - 24.90) 2002 Modelled IHME
19 (14.40 - 25.30) 2001 Modelled IHME
19.1 (14.50 - 25.30) 2000 Modelled IHME
19.5 (14.80 - 25.80) 1999 Modelled IHME
19.5 (14.80 - 25.90) 1998 Modelled IHME
19.2 (14.50 - 25.40) 1997 Modelled IHME
19 (14.10 - 25.20) 1996 Modelled IHME
18.7 (13.80 - 25.10) 1995 Modelled IHME
18.7 (13.10 - 25.70) 1994 Modelled IHME
18.8 (13.50 - 25.80) 1993 Modelled IHME
19.1 (13.30 - 26.30) 1992 Modelled IHME
19.2 (12.60 - 26.70) 1991 Modelled IHME
19.3 (13.30 - 27.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
23 (16 - 32) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
22 (15 - 30) 2017 Modelled IHME
22 (15 - 30) 2016 Modelled IHME
22 (15 - 30) 2015 Modelled IHME
22 (16 - 30) 2014 Modelled IHME
23 (17 - 30) 2013 Modelled IHME
24 (19 - 31) 2012 Modelled IHME
25 (20 - 32) 2011 Modelled IHME
26 (21 - 34) 2010 Modelled IHME
26 (21 - 34) 2009 Modelled IHME
26 (20 - 34) 2008 Modelled IHME
27 (21 - 35) 2007 Modelled IHME
27 (20 - 35) 2006 Modelled IHME
26 (19 - 34) 2005 Modelled IHME
27 (21 - 36) 2004 Modelled IHME
27 (20 - 36) 2003 Modelled IHME
28 (21 - 37) 2002 Modelled IHME
28 (21 - 37) 2001 Modelled IHME
27 (21 - 36) 2000 Modelled IHME
28 (21 - 36) 1999 Modelled IHME
27 (21 - 36) 1998 Modelled IHME
26 (20 - 35) 1997 Modelled IHME
26 (19 - 34) 1996 Modelled IHME
25 (18 - 33) 1995 Modelled IHME
24 (17 - 34) 1994 Modelled IHME
24 (17 - 33) 1993 Modelled IHME
24 (17 - 33) 1992 Modelled IHME
24 (16 - 33) 1991 Modelled IHME
24 (16 - 33) 1990 Modelled IHME
30 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
49 (41 - 57) 2019 Modelled IHME
49 (41 - 57) 2018 Modelled IHME
49 (41 - 57) 2017 Modelled IHME
49 (41 - 57) 2016 Modelled IHME
49 (41 - 57) 2015 Modelled IHME
49 (41 - 57) 2014 Modelled IHME
49 (41 - 58) 2013 Modelled IHME
49 (41 - 58) 2012 Modelled IHME
49 (41 - 58) 2011 Modelled IHME
50 (41 - 58) 2010 Modelled IHME
49 (41 - 58) 2009 Modelled IHME
49 (41 - 58) 2008 Modelled IHME
49 (41 - 57) 2007 Modelled IHME
49 (41 - 57) 2006 Modelled IHME
48 (40 - 57) 2005 Modelled IHME
49 (41 - 57) 2004 Modelled IHME
49 (41 - 57) 2003 Modelled IHME
49 (41 - 58) 2002 Modelled IHME
49 (41 - 58) 2001 Modelled IHME
49 (41 - 58) 2000 Modelled IHME
49 (41 - 58) 1999 Modelled IHME
49 (41 - 58) 1998 Modelled IHME
49 (41 - 58) 1997 Modelled IHME
49 (40 - 57) 1996 Modelled IHME
49 (40 - 58) 1995 Modelled IHME
49 (40 - 58) 1994 Modelled IHME
49 (40 - 58) 1993 Modelled IHME
49 (40 - 58) 1992 Modelled IHME
49 (41 - 58) 1991 Modelled IHME
49 (41 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
95 2018 Survey/reported WHO/UNICEF
95 2017 Survey/reported WHO/UNICEF
96 2016 Survey/reported WHO/UNICEF
96 2015 Survey/reported WHO/UNICEF
95 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
96 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
98 2010 Survey/reported WHO/UNICEF
98 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
87 2007 Survey/reported WHO/UNICEF
75 2006 Survey/reported WHO/UNICEF
96 2005 Survey/reported WHO/UNICEF
70 2004 Survey/reported WHO/UNICEF
43 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2018
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.4 (1.92 - 3) 2019 Modelled IHME
2.39 (1.92 - 2.99) 2018 Modelled IHME
2.39 (1.92 - 2.99) 2017 Modelled IHME
2.38 (1.92 - 2.97) 2016 Modelled IHME
2.38 (1.91 - 2.98) 2015 Modelled IHME
2.39 (1.92 - 2.99) 2014 Modelled IHME
2.4 (1.93 - 3) 2013 Modelled IHME
2.43 (1.95 - 3.02) 2012 Modelled IHME
2.45 (1.97 - 3.06) 2011 Modelled IHME
2.47 (1.98 - 3.08) 2010 Modelled IHME
2.49 (2 - 3.11) 2009 Modelled IHME
2.52 (2.02 - 3.14) 2008 Modelled IHME
2.54 (2.04 - 3.18) 2007 Modelled IHME
2.57 (2.05 - 3.21) 2006 Modelled IHME
2.59 (2.06 - 3.25) 2005 Modelled IHME
2.62 (2.08 - 3.28) 2004 Modelled IHME
2.64 (2.11 - 3.32) 2003 Modelled IHME
2.67 (2.14 - 3.37) 2002 Modelled IHME
2.69 (2.16 - 3.39) 2001 Modelled IHME
2.71 (2.19 - 3.42) 2000 Modelled IHME
2.73 (2.20 - 3.45) 1999 Modelled IHME
2.75 (2.22 - 3.47) 1998 Modelled IHME
2.76 (2.23 - 3.47) 1997 Modelled IHME
2.78 (2.25 - 3.49) 1996 Modelled IHME
2.79 (2.25 - 3.51) 1995 Modelled IHME
2.8 (2.26 - 3.52) 1994 Modelled IHME
2.81 (2.27 - 3.53) 1993 Modelled IHME
2.82 (2.28 - 3.54) 1992 Modelled IHME
2.83 (2.29 - 3.55) 1991 Modelled IHME
2.84 (2.28 - 3.56) 1990 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.75 (1.15 - 2.61) 2019 Modelled IHME
1.74 (1.15 - 2.59) 2018 Modelled IHME
1.73 (1.15 - 2.55) 2017 Modelled IHME
1.69 (1.14 - 2.47) 2016 Modelled IHME
1.65 (1.11 - 2.45) 2015 Modelled IHME
1.66 (1.13 - 2.42) 2014 Modelled IHME
1.62 (1.14 - 2.34) 2013 Modelled IHME
1.61 (1.16 - 2.31) 2012 Modelled IHME
1.65 (1.20 - 2.33) 2011 Modelled IHME
1.73 (1.26 - 2.43) 2010 Modelled IHME
1.76 (1.27 - 2.46) 2009 Modelled IHME
1.79 (1.30 - 2.53) 2008 Modelled IHME
1.87 (1.35 - 2.64) 2007 Modelled IHME
1.89 (1.36 - 2.68) 2006 Modelled IHME
1.85 (1.33 - 2.63) 2005 Modelled IHME
1.98 (1.41 - 2.79) 2004 Modelled IHME
1.98 (1.40 - 2.80) 2003 Modelled IHME
2.05 (1.45 - 2.93) 2002 Modelled IHME
2.05 (1.45 - 2.97) 2001 Modelled IHME
2.06 (1.45 - 2.96) 2000 Modelled IHME
2.09 (1.47 - 2.97) 1999 Modelled IHME
2.08 (1.47 - 2.95) 1998 Modelled IHME
2.04 (1.43 - 2.87) 1997 Modelled IHME
2.01 (1.39 - 2.82) 1996 Modelled IHME
1.98 (1.36 - 2.80) 1995 Modelled IHME
1.98 (1.29 - 2.81) 1994 Modelled IHME
1.99 (1.35 - 2.93) 1993 Modelled IHME
2.03 (1.29 - 2.95) 1992 Modelled IHME
2.05 (1.30 - 3.02) 1991 Modelled IHME
2.08 (1.36 - 3.11) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
4 (2 - 5) 2019 Modelled IHME
4 (2 - 5) 2018 Modelled IHME
3 (2 - 5) 2017 Modelled IHME
3 (2 - 5) 2016 Modelled IHME
3 (2 - 5) 2015 Modelled IHME
3 (2 - 5) 2014 Modelled IHME
3 (2 - 4) 2013 Modelled IHME
3 (2 - 4) 2012 Modelled IHME
3 (2 - 4) 2011 Modelled IHME
3 (2 - 4) 2010 Modelled IHME
3 (2 - 4) 2009 Modelled IHME
3 (2 - 4) 2008 Modelled IHME
3 (2 - 4) 2007 Modelled IHME
3 (2 - 4) 2006 Modelled IHME
3 (2 - 4) 2005 Modelled IHME
3 (2 - 4) 2004 Modelled IHME
3 (2 - 4) 2003 Modelled IHME
3 (2 - 4) 2002 Modelled IHME
3 (2 - 4) 2001 Modelled IHME
3 (2 - 4) 2000 Modelled IHME
3 (2 - 4) 1999 Modelled IHME
3 (2 - 4) 1998 Modelled IHME
3 (2 - 4) 1997 Modelled IHME
3 (2 - 4) 1996 Modelled IHME
3 (2 - 4) 1995 Modelled IHME
3 (2 - 4) 1994 Modelled IHME
3 (2 - 4) 1993 Modelled IHME
3 (2 - 4) 1992 Modelled IHME
3 (2 - 4) 1991 Modelled IHME
3 (2 - 4) 1990 Modelled IHME
8 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
15 (11 - 21) 2019 Modelled IHME
16 (11 - 21) 2018 Modelled IHME
16 (11 - 21) 2017 Modelled IHME
16 (11 - 21) 2016 Modelled IHME
16 (11 - 22) 2015 Modelled IHME
16 (11 - 22) 2014 Modelled IHME
16 (11 - 22) 2013 Modelled IHME
17 (12 - 22) 2012 Modelled IHME
17 (12 - 22) 2011 Modelled IHME
17 (11 - 22) 2010 Modelled IHME
17 (11 - 22) 2009 Modelled IHME
17 (12 - 22) 2008 Modelled IHME
17 (12 - 23) 2007 Modelled IHME
17 (12 - 23) 2006 Modelled IHME
18 (12 - 24) 2005 Modelled IHME
17 (12 - 23) 2004 Modelled IHME
18 (12 - 24) 2003 Modelled IHME
17 (12 - 23) 2002 Modelled IHME
18 (12 - 24) 2001 Modelled IHME
18 (12 - 24) 2000 Modelled IHME
18 (12 - 24) 1999 Modelled IHME
18 (12 - 24) 1998 Modelled IHME
18 (12 - 24) 1997 Modelled IHME
18 (12 - 24) 1996 Modelled IHME
18 (13 - 25) 1995 Modelled IHME
18 (12 - 25) 1994 Modelled IHME
18 (12 - 25) 1993 Modelled IHME
18 (12 - 25) 1992 Modelled IHME
18 (12 - 25) 1991 Modelled IHME
18 (12 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2018
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
7.13 (%)
2019
(5.85 - 8.41(%))
IHME
HCV (RNA/cAg+)
2.4 (%)
2019
(1.92 - 3(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
23
2019
(16 - 32)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
4
2019
(2 - 5)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.93 (%)
2019, latest modelled
(0.66 - 1.19(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources